Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

How many medications do doctors in primary care use? An observational study of the DU90% indicator in primary care in England

Chiamaka Chiedozie, View ORCID ProfileMark Murphy, View ORCID ProfileTom Fahey, View ORCID ProfileFrank Moriarty
doi: https://doi.org/10.1101/2020.06.16.20132654
Chiamaka Chiedozie
1HRB Centre for Primary Care Research, Department of General Practice, Royal College of Surgeons in Ireland
2School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Murphy
1HRB Centre for Primary Care Research, Department of General Practice, Royal College of Surgeons in Ireland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mark Murphy
Tom Fahey
1HRB Centre for Primary Care Research, Department of General Practice, Royal College of Surgeons in Ireland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tom Fahey
Frank Moriarty
1HRB Centre for Primary Care Research, Department of General Practice, Royal College of Surgeons in Ireland
2School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Frank Moriarty
  • For correspondence: frankmoriarty{at}rcsi.ie
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Aim To apply the DU90% indicator (the number of unique drugs which make up 90% of a doctor’s prescribing) to GP practices prescribing in England to examine time trends, practice-level variation, and relationships with practice characteristics

Method This is an observational cohort study of all general practices in England. It utilises publicly available prescribing data from the National Health Service (NHS) Digital platform for 2013-2017. The DU90% was calculated on an annual basis for each practice based on medication BNF codes. Descriptive statistics were generated per year on time trends and practice-level variation in the DU90%. Multi-level linear regression was used to examine the practice characteristics (relating to staff, patients, and deprivation of the practice area).

Results A total of 7,623 GP practices were included. The mean DU90% ranged from 130.1 to 133.4 across study years, and variation between practices was low (with a 1.4 fold difference between the lowest and highest 5% of practices). A range of medications were included in the DU90% of virtually all practices, including atorvastatin, levothyroxine, omeprazole, ramipril, amlodipine, simvastatin and aspirin. A higher volume of prescribing was associated with a lower DU90%, while having more patients, higher proportions of patients who are female or aged 65+, higher number of GPs working in the practice, and being in a more deprived area were associated with a higher DU90%.

Conclusion GP practices typically use 130 different medications in the bulk of their prescribing. Increasing use of personal formularies may enhance prescribing quality and reduce costs.

  1. What is already known about this subject:

    • Prescribers can develop expertise in a finite number of drugs, hence use of a personal formulary is recommended and may enhance prescribing quality

    • The drug utilisation 90% (DU90%), a measure of the number of drugs that comprises 90% of prescribing volume, has not been applied to prescribing in England to date.

  2. What this study adds:

    • On average, 130 medicines make up 90% of prescribing in GP practices in England.

    • Practices with a lower DU90% tended to have lower prescribing costs and less prescribing considered low-value care.

    • Rationalising prescribing to focus on a smaller group of medicines may enhance quality and reduce costs.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was funded by the Health Research Board in Ireland (HRB) through the Summer Student Scholarships (grant no. SS/2018/080) and the HRB Centre for Primary Care Research (HRC/2014/01), and supported by the Royal College of Surgeons in Ireland Undergraduate Research Summer School.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study reuses publicly available data.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Principal investigator statement: This study did not have a Principal Investigator, as it reports an analysis of publicly available administrative data.

Data Availability

The data that support the findings of this study are openly available in Zenodo at https://doi.org/10.5281/zenodo.3894539.

https://doi.org/10.5281/zenodo.3894539

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted June 19, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
How many medications do doctors in primary care use? An observational study of the DU90% indicator in primary care in England
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
How many medications do doctors in primary care use? An observational study of the DU90% indicator in primary care in England
Chiamaka Chiedozie, Mark Murphy, Tom Fahey, Frank Moriarty
medRxiv 2020.06.16.20132654; doi: https://doi.org/10.1101/2020.06.16.20132654
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
How many medications do doctors in primary care use? An observational study of the DU90% indicator in primary care in England
Chiamaka Chiedozie, Mark Murphy, Tom Fahey, Frank Moriarty
medRxiv 2020.06.16.20132654; doi: https://doi.org/10.1101/2020.06.16.20132654

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Primary Care Research
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)